PTO Form 1478 (Rev 9/2006) |
OMB No. 0651-0009 (Exp 12/31/2014) |
Trademark/Service Mark Application, Principal Register
Serial Number: 86489837 |
Filing Date: 12/23/2014 |
The table below presents the data as entered.
Input Field
|
Entered
|
SERIAL NUMBER |
86489837 |
MARK INFORMATION |
*MARK |
\\TICRS\EXPORT16\IMAGEOUT 16\864\898\86489837\xml1\ APP0002.JPG |
SPECIAL FORM |
YES |
USPTO-GENERATED IMAGE |
NO |
LITERAL ELEMENT |
DYNAVAX INNOVATING IMMUNOLOGY |
COLOR MARK |
YES |
COLOR(S) CLAIMED
(If applicable) |
The color(s) green and blue is/are claimed as a feature of the mark. |
*DESCRIPTION OF THE MARK
(and Color Location, if applicable) |
The mark consists of the words DYNAVAX INNOVATING IMMUNOLOGY with the word DYNAVAX in stylized lettering, centered above INNOVATING IMMUNOLOGY. The
first three and last two letters of DYNAVAX are bright green and the fourth and fifth letters, "A" and "V" are stylized and in the color blue. The words INNOVATING IMMUNOLOGY are in blue. |
PIXEL COUNT ACCEPTABLE |
NO |
PIXEL COUNT |
912 x 245 |
REGISTER |
Principal |
APPLICANT INFORMATION |
*OWNER OF MARK |
Dynavax Technologies Corporation |
*STREET |
2929 Seventh Street, Suite 100 |
*CITY |
Berkeley |
*STATE
(Required for U.S. applicants) |
California |
*COUNTRY |
United States |
*ZIP/POSTAL CODE
(Required for U.S. applicants only) |
94710-2722 |
EMAIL ADDRESS |
XXXX |
LEGAL ENTITY INFORMATION |
TYPE |
corporation |
STATE/COUNTRY OF INCORPORATION |
Delaware |
GOODS AND/OR SERVICES AND BASIS INFORMATION |
INTERNATIONAL CLASS |
042 |
*IDENTIFICATION |
Pharmaceutical and biological research, testing and product development consultation; pharmaceutical and biological research, testing and
product development for others; vaccine research and development |
FILING BASIS |
SECTION 1(b) |
ADDITIONAL STATEMENTS SECTION |
PRIOR REGISTRATION(S) |
The applicant claims ownership of U.S. Registration Number(s) 3366555 and 3307735. |
ATTORNEY INFORMATION |
NAME |
Beth M. Goldman |
ATTORNEY DOCKET NUMBER |
21557.1 |
FIRM NAME |
Orrick, Herrington & Sutcliffe LLP |
INTERNAL ADDRESS |
IP Prosecution |
STREET |
2050 Main Street, Suite 1100 |
CITY |
Irvine |
STATE |
California |
COUNTRY |
United States |
ZIP/POSTAL CODE |
92614 |
PHONE |
415 773 5700 |
FAX |
415 773 5759 |
EMAIL ADDRESS |
ipprosecutionsf@orrick.com |
AUTHORIZED TO COMMUNICATE VIA EMAIL |
Yes |
OTHER APPOINTED ATTORNEY |
Betsy Wang Lee, Thomas H. Zellerbach, Diana M. Rutowski, Kristin S. Cornuelle, Mary Beth Myles, Daniel Justice, Eileen Aghnami |
CORRESPONDENCE INFORMATION |
NAME |
Beth M. Goldman |
FIRM NAME |
Orrick, Herrington & Sutcliffe LLP |
INTERNAL ADDRESS |
IP Prosecution |
STREET |
2050 Main Street, Suite 1100 |
CITY |
Irvine |
STATE |
California |
COUNTRY |
United States |
ZIP/POSTAL CODE |
92614 |
PHONE |
415 773 5700 |
FAX |
415 773 5759 |
EMAIL ADDRESS |
ipprosecutionsf@orrick.com;beth.goldman@orrick.com; eaghnami@orrick.com; susanne.renner@orrick.com |
AUTHORIZED TO COMMUNICATE VIA EMAIL |
Yes |
FEE INFORMATION |
NUMBER OF CLASSES |
1 |
FEE PER CLASS |
325 |
*TOTAL FEE DUE |
325 |
*TOTAL FEE PAID |
325 |
SIGNATURE INFORMATION |
SIGNATURE |
/Michael S. Ostrach/ |
SIGNATORY'S NAME |
Michael S. Ostrach |
SIGNATORY'S POSITION |
Vice President, Chief Business Officer |
DATE SIGNED |
12/23/2014 |
PTO Form 1478 (Rev 9/2006) |
OMB No. 0651-0009 (Exp 12/31/2014) |
Trademark/Service Mark Application, Principal Register
Serial Number: 86489837 |
Filing Date: 12/23/2014 |
To the Commissioner for Trademarks:
MARK: DYNAVAX INNOVATING IMMUNOLOGY (stylized and/or with design, see
mark)
The literal element of the mark consists of DYNAVAX INNOVATING IMMUNOLOGY.
The color(s) green and blue is/are claimed as a feature of the mark. The mark consists of the words DYNAVAX INNOVATING IMMUNOLOGY with the word DYNAVAX in stylized lettering, centered above
INNOVATING IMMUNOLOGY. The first three and last two letters of DYNAVAX are bright green and the fourth and fifth letters, "A" and "V" are stylized and in the color blue. The words INNOVATING
IMMUNOLOGY are in blue.
The applicant, Dynavax Technologies Corporation, a corporation of Delaware, having an address of
2929 Seventh Street, Suite 100
Berkeley, California 94710-2722
United States
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 042: Pharmaceutical and biological research, testing and product development consultation; pharmaceutical and biological research,
testing and product development for others; vaccine research and development
Intent to Use: The applicant has a bona fide intention to use or use through the applicant's related company or licensee the mark in commerce on or in connection with the identified goods and/or
services. (15 U.S.C. Section 1051(b)).
The applicant claims ownership of U.S. Registration Number(s) 3366555 and 3307735.
The applicant's current Attorney Information:
Beth M. Goldman and Betsy Wang Lee, Thomas H. Zellerbach, Diana M. Rutowski, Kristin S. Cornuelle, Mary Beth Myles, Daniel Justice, Eileen Aghnami of Orrick,
Herrington & Sutcliffe LLP
IP Prosecution
2050 Main Street, Suite 1100
Irvine, California 92614
United States
The attorney docket/reference number is 21557.1.
The applicant's current Correspondence Information: |
Beth M. Goldman |
Orrick, Herrington & Sutcliffe LLP |
IP Prosecution
2050 Main Street, Suite 1100 |
Irvine, California 92614 |
415 773 5700(phone) |
415 773 5759(fax) |
ipprosecutionsf@orrick.com;beth.goldman@orrick.com; eaghnami@orrick.com; susanne.renner@orrick.com (authorized) |
A fee payment in the amount of $325 has been submitted with the application, representing payment for 1 class(es).
Declaration
The signatory believes that: if the applicant is filing the application under 15 U.S.C. Section 1051(a), the applicant is the owner of the trademark/service mark sought to be registered; the
applicant or the applicant's related company or licensee is using the mark in commerce on or in connection with the goods/services in the application, and such use by the applicant's related company
or licensee inures to the benefit of the applicant; the specimen(s) shows the mark as used on or in connection with the goods/services in the application; and/or if the applicant filed an application
under 15 U.S.C. Section 1051(b), Section 1126(d), and/or Section 1126(e), the applicant is entitled to use the mark in commerce; the applicant has a bona fide intention to use or use through the
applicant's related company or licensee the mark in commerce on or in connection with the goods/services in the application. The signatory believes that to the best of the signatory's knowledge and
belief, no other person has the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services of
such other person, to cause confusion or mistake, or to deceive. The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C.
Section 1001, and that such willful false statements and the like may jeopardize the validity of the application or any registration resulting therefrom, declares that all statements made of his/her
own knowledge are true and all statements made on information and belief are believed to be true.
Declaration Signature
Signature: /Michael S. Ostrach/ Date: 12/23/2014
Signatory's Name: Michael S. Ostrach
Signatory's Position: Vice President, Chief Business Officer
RAM Sale Number: 86489837
RAM Accounting Date: 12/24/2014
Serial Number: 86489837
Internet Transmission Date: Tue Dec 23 20:15:35 EST 2014
TEAS Stamp: USPTO/BAS-XX.XXX.XXX.XXX-201412232015354
72512-86489837-5006ab094b989bc617c42187d
aae457931ebb8c96166b6e7aa1ec795cc535846c
a3-DA-20075-20141219182905139483